Shaw Christine

VP, Assay Development at GenMark Diagnostics, Inc.

Sold, on record
$86k
Dollars the filings state
Form 4 sales
9
Latest Mar 5, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale GenMark Diagnostics, Inc.Plan not stated
    Sep 8, 2020 2020

    Sold 285 shares at $11.02 ($3k)

    Shaw Christine, VP, Assay Development

    Sold 0.4% of holdings ($882k position)79,714 shares leftFiling

  2. 2 Form 4 sale GenMark Diagnostics, Inc.Plan not stated
    Oct 27, 2020 +49 days

    Sold 68 shares at $11.34 ($771)

    Shaw Christine, VP, Assay Development

    Sold 0.1% of holdings ($904k position)79,646 shares leftFiling

  3. 3 Form 4 sale GenMark Diagnostics, Inc.Plan not stated
    Nov 24, 2020 +28 days

    Sold 355 shares at $13.17 ($5k)

    Shaw Christine, VP, Assay Development

    Sold 0.4% of holdings ($1M position)79,291 shares left1.2x usual sizeFiling

  4. 4 Form 4 sale GenMark Diagnostics, Inc.Plan not stated
    Dec 7, 2020 +13 days

    Sold 274 shares at $13.97 ($4k)

    Shaw Christine, VP, Assay Development

    Sold 0.3% of holdings ($1.1M position)79,877 shares left0.9x usual sizeFiling

  5. 5 Form 4 sale GenMark Diagnostics, Inc.Plan not stated
    Jan 27, 2021 +51 days

    Sold 81 shares at $14.06 ($1k)

    Shaw Christine, VP, Assay Development

    Sold 0.1% of holdings ($1.1M position)79,796 shares left0.3x usual sizeFiling

  6. 6 Form 4 sale GenMark Diagnostics, Inc.Plan not stated
    Feb 24, 2021 +28 days

    Sold 425 shares at $19.21 ($8k)

    Shaw Christine, VP, Assay Development

    Sold 0.4% of holdings ($2M position)105,621 shares left1.5x usual sizeFiling

  7. 7 Form 4 sale GenMark Diagnostics, Inc.Unusual
    Feb 26, 2021 +2 days

    Sold 3,151 shares at $17.03 ($54k)

    Shaw Christine, VP, Assay Development

    Sold 3% of holdings ($1.8M position)102,470 shares left11.1x usual sizeFiling

  8. 8 Form 4 sale GenMark Diagnostics, Inc.Plan not stated
    Mar 5, 2021 +7 days

    Sold 274 shares at $18.56 ($5k)

    Shaw Christine, VP, Assay Development

    Sold 0.3% of holdings ($1.9M position)102,196 shares left0.9x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by Shaw Christine
Source
Mar 5, 2021Mar 8, 2021GenMark Diagnostics, Inc.VP, Assay DevelopmentForm 4 sale274$5k0.3%Plan not statedSEC
Feb 26, 2021Mar 1, 2021GenMark Diagnostics, Inc.VP, Assay DevelopmentForm 4 sale3,151$54k3.0%UnusualSEC
Feb 24, 2021Feb 25, 2021GenMark Diagnostics, Inc.VP, Assay DevelopmentForm 4 sale425$8k0.4%Plan not statedSEC
Jan 27, 2021Jan 29, 2021GenMark Diagnostics, Inc.VP, Assay DevelopmentForm 4 sale81$1k0.1%Plan not statedSEC
Dec 7, 2020Dec 9, 2020GenMark Diagnostics, Inc.VP, Assay DevelopmentForm 4 sale274$4k0.3%Plan not statedSEC
Nov 24, 2020Nov 25, 2020GenMark Diagnostics, Inc.VP, Assay DevelopmentForm 4 sale355$5k0.4%Plan not statedSEC
Oct 27, 2020Oct 29, 2020GenMark Diagnostics, Inc.VP, Assay DevelopmentForm 4 sale68$7710.1%Plan not statedSEC
Sep 8, 2020Sep 10, 2020GenMark Diagnostics, Inc.VP, Assay DevelopmentForm 4 sale285$3k0.4%Plan not statedSEC
Aug 25, 2020Aug 26, 2020GenMark Diagnostics, Inc.VP, Assay DevelopmentForm 4 sale379$5k0.5%Plan not statedSEC